Evogene
Mr. Dan Falk joined Evogene’s Board of Directors in November 2021 and has extensive experience of more than 20 years in serving as a financial expert on public and private company boards, most recently on the boards of Nice Ltd. (NASDAQ: NICE), Ormat Technologies Inc. (NYSE: ORA) and Innoviz Technologies Ltd. (NASDAQ: INVZ). Additionally, in the past Mr. Falk held various executive positions in Orbotech Ltd. and Sapiens International Corporation (NASDAQ: SPNS).
Mr. Falk holds a BA in Economics and Political Science, and an MA in Business Administration both from the Hebrew University of Jerusalem.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Evogene
2 followers
Evogene Ltd. is an Israeli company engaged in research and development for improving crop quality, productivity and economics, through application of plant genomics, for the food, feed and biofuel industries.